Form D · Other Health Care

Klothea Bio, Inc.

Miami, FL · CIK 0002042705

Offering snapshot reported Sep 8, 2026 · SEC filing

Reported sold: $6.89M
Investors reported: 22
Minimum accepted: $0
First sale: Oct 11, 2024

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$5,935,000 → $6,885,000
Reported investors18 → 22

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Sep 8, 2026	Amendment	$6,885,000	$950,000vs May 28, 2026	22	SEC filing
May 28, 2026	Amendment	$5,935,000	$3,000,000vs Feb 2, 2026	18	SEC filing
Feb 2, 2026	Amendment	$2,935,000	No comparison	11	SEC filing
Oct 28, 2024	Initial	$1,000,000	No comparison	1	SEC filing

Offering details

Securities: Debt, Option to acquire, Security to be acquired
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $12.5K (estimated)
Finders' fees: $0
Form D file number: 021-527956

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Scott Hamilton Ryan	7097428	Finalis Securities, LLC · CRD 305908

Source: Form D, filed Sep 8, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Agustin Fernandez Santana Iii	Director, Executive
Olivier Jarry	Executive
Jeffrey B. Madden	Director, Executive
Walter Schmidt	Director
Petr Sramek	Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:

195 Nw 40 Th Street
Miami, FL, 33127